Ensign Peak Advisors
ADAP

Ensign Peak Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-43,285
Closed -$345K 1853
2020
Q3
$345K Sell
43,285
-2,169
-5% -$17.3K ﹤0.01% 1597
2020
Q2
$455K Buy
+45,454
New +$455K ﹤0.01% 1482